克利夫兰生物实验室(CBLI.US)盘前大涨18.76%,报5.76美元。公司与美国细胞通信公司Cytocom宣布合并登记声明和委托声明。 网页链接
$克利夫兰生物实验室(CBLI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-19-022938 Act: 34 Size: 3 MB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-19-022930 Act: 34 Size: 164 KB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2019-10-23 AccNo: 0001437749-19-020455 Size: 31 KBItem 8.01: Other Events 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2019-08-23 AccNo: 0001318641-19-000027 Size: 28 KBItem 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2019-08-14 AccNo: 0001318641-19-000024 Size: 170 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$克利夫兰生物实验室(CBLI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-14 AccNo: 0001318641-19-000025 Size: 3 MB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2019-05-30 AccNo: 0001318641-19-000021 Size: 24 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2019-05-15 AccNo: 0001318641-19-000018 Size: 144 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$克利夫兰生物实验室(CBLI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-05-15 AccNo: 0001318641-19-000019 Size: 6 MB 网页链接
$克利夫兰生物实验室(CBLI)$ 8-K - Current report Filed: 2019-04-29 AccNo: 0001318641-19-000013 Size: 32 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接